Mario Pávez
Impact in
-
- Diabetes Treatment and Management
- Hormonal and reproductive studies
-
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
Papers in
-
- Mitochondrial Function and Pathology 6
- Metabolism, Diabetes, and Cancer 2
- Receptor Mechanisms and Signaling 2
- ATP Synthase and ATPases Research 2
- Co-authors
- Dirk J. van Veldhuisen (3 shared papers)B. Daan Westenbrink (7 shared papers)Herman H.W. Silljé (5 shared papers)Rudolf A. de Boer (5 shared papers)Silke U. Oberdorf‐Maass (4 shared papers)Salva R. Yurista (3 shared papers)Jan‐Luuk Hillebrands (1 shared paper)Harry van Goor (1 shared paper)
- Journals
- PLoS ONE (2 papers)International Journal of Molecular Sciences (2 papers)Pharmacological Research (1 paper)The FASEB Journal (1 paper)Frontiers in Physiology (1 paper)
- Partner nations
- ChileNetherlandsUnited States
In The Last Decade
Mario Pávez
18 papers receiving 649 citations
Mario Pávez's Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 219
- Cardiology and Cardiovascular Medicine 219
- Molecular Biology 236
- Physiology 78
- Surgery 109
Countries citing papers authored by Mario Pávez
This map shows the geographic impact of Mario Pávez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Pávez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Pávez more than expected).
Fields of papers citing papers by Mario Pávez
This network shows the impact of papers produced by Mario Pávez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Pávez. The network helps show where Mario Pávez may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Pávez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin Improves Cardiac Function in Non-Diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction Hit paper breakdown → | 2019 | 254 |
| 2 | 2016 | 93 | |
| 3 | 2013 | 46 | |
| 4 | 2022 | 43 | |
| 5 | 2016 | 36 | |
| 6 | 2017 | 25 | |
| 7 | 2013 | 24 | |
| 8 | 2021 | 23 | |
| 9 | 2015 | 22 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 18 | |
| 12 | 2016 | 16 | |
| 13 | 2021 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2022 | 8 | |
| 16 | 2024 | 3 | |
| 17 | 2012 | 2 | |
| 18 | 2021 | 1 |
About Mario Pávez
Mario Pávez is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology, having authored 18 papers that have together received 657 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (6 papers), Hormonal and reproductive studies (3 papers), Metabolism and Genetic Disorders (2 papers), Adenosine and Purinergic Signaling (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Receptor Mechanisms and Signaling (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (219 citations), Cardiology and Cardiovascular Medicine (219 citations), Molecular Biology (236 citations), Physiology (78 citations) and Surgery (109 citations). Mario Pávez has collaborated with scholars based in Chile, Netherlands and United States. Frequent co-authors include Dirk J. van Veldhuisen, B. Daan Westenbrink, Herman H.W. Silljé, Rudolf A. de Boer, Silke U. Oberdorf‐Maass, Salva R. Yurista, Jan‐Luuk Hillebrands, Harry van Goor, Sergio Lavandero and Javier Nebreda Durán. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Pharmacological Research, The FASEB Journal and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.